The journal explores how disruptions in microbial balance contribute to disease progression. It features research on dysbiosis in metabolic syndrome, obesity, IBD, IBS, and autoimmune disorders. Studies highlight microbial triggers of inflammation and altered signaling pathways. The aim is to identify microbiome-derived factors that initiate or aggravate disease. This helps pave the way for targeted diagnostic and therapeutic strategies.